📋 Tender Overview
Contract awarded for C/ base no cpa 2023_491 lot-0013, title: brodalumab 210 mg/1.5 ml sol inj ser 1.5 ml sc, description: acquisition of 'brodalumab 210 mg/1.5 ml sol inj ser 1.5 ml sc' estimated value excluding vat: 36904.00 eur.C/ base no cpa 2023_491